InvestorsHub Logo

Karlchen

03/27/19 4:56 AM

#220052 RE: Lykiri #220026

We Germans are nice, anyway . . .

seriosely - in ALL nations are good and bad . .

my 2 cents on this report, you don´t need to translate - it says all the good we know anyway. First paragraphs about the advanced operations and chemo, last paragraphs about our studies . .

einen schönen Tag

john1045

03/27/19 5:42 AM

#220054 RE: Lykiri #220026

Great find Lykiri! He mentioned 223 patients at 2 years which I found interesting number if he meant alive?

After surgery on the brain tumor: Neurosurgery refers to new study results from America
The study, which was not yet completed, showed that the participants after the surgery plus chemotherapy with a new drug compared to the standard therapy lived significantly longer. The drug DCVax® was used after surgery and chemotherapy. The first results of the study show that of the 331 participants, about one-third lived longer than three years after therapy after taking the drug. After two years, there were 223 patients. The drug is a vaccine that trains the immune system to attack the tumor cells. Monocytes are extracted from the blood of the patient, which are then developed into dendritic cells and brought into contact with the patient's tumor samples. The cells should be trained on the handling of glioblastoma cells.



http://www.neurochirurgie-diakonie.de/tumor-impfung-bei-hirntumor-informationen-aus-siegen/